I Can't Think of a Better Vanguard ETF to Buy During the Stock Market Sell-Off Than This One
Market Decline Factors: The recent market decline is attributed to high valuations and disappointing earnings in tech stocks, poor job growth raising recession fears, and the Bank of Japan's interest rate hike, prompting investors to sell stocks.
Recommended Vanguard ETF: In light of these conditions, the Vanguard Long-Term Bond ETF is highlighted as a strong investment choice due to its performance during market volatility, low expense ratio, and safety from U.S. government bonds.
Trade with 70% Backtested Accuracy
Analyst Views on VB
About the author
Kratos Secures Contract Valued at One-Third of Its Fiscal 2025 Revenue – KTOS Stock Soars in Early Trading
Kraton’s New Contract: Kratos has been awarded a $446.8 million contract to serve as the prime contractor supporting the U.S. Space Force's Systems Command, focusing on ground management and integration for missile warning and tracking programs.
Revenue Growth: The contract is expected to contribute significantly to Kratos' revenue, which is projected to reach $1.35 billion in 2025, reflecting a nearly 17% growth compared to 2024.
Team Composition: Kratos will lead a team that includes Northrop Grumman, AURIA, ASRC Federal Systems Solutions, and Rise8, aiming to unify legacy and next-generation ground assets into a scalable global network.
Stock Performance: Following the contract announcement, Kratos shares rose nearly 7%, and the company has seen a year-to-date stock increase of 2% and a 167% rise over the past 12 months.
MDGL Stock Rises Significantly in a Month Amid Eli Lilly Acquisition Rumors
Madrigal's Focus: Madrigal is concentrating on developing therapies for metabolic dysfunction associated with MASH, with its Rezdiffran drug already approved by the U.S. FDA for treating moderate to advanced fibrosis.
Financial Performance: The company reported Rezdiffran sales of $958.4 million for the full year 2025, with over 36,250 patients on the drug by the end of that year.
Expansion Plans: Madrigal has licensed global rights to six pre-clinical siRNA programs for up to $4.4 billion to expand its pipeline and is evaluating the drug for treating compensated MASH cirrhosis.
Market Reaction: Following speculation about a potential buyout by Eli Lilly, Madrigal's stock saw a significant increase, with retail sentiment shifting from neutral to extremely bullish.
The Case for Retirees to Welcome Market Volatility
- Market Uncertainty: High levels of uncertainty in the market can be beneficial for stocks, contrary to the common belief that it leads to negative outcomes.
- Retirement Portfolio Consideration: Investors should keep in mind the potential positive effects of uncertainty when managing their retirement portfolios.
Vanguard Small-Cap ETF announces quarterly payout of $0.9268
Dividend Information: Vanguard Small-Cap ETF (VB) has a dividend of $0.9268, with a 30-Day SEC Yield of 1.33% as of November 30. The dividend is payable on December 24 for shareholders of record on December 22, with an ex-dividend date also on December 22.
Market Sentiment: Small-cap stocks, represented by the Vanguard Small-Cap ETF, are currently out of favor in the market, which may present compelling investment opportunities according to Seeking Alpha’s analysis.
Significant ETF Withdrawals Observed - VB, SOFI, NRG, EME
Stock Performance: VB's share price is currently at $259.74, within a 52-week range of $190.27 to $261.76, indicating a relatively stable position near its high.
ETFs Overview: Exchange traded funds (ETFs) function like stocks, allowing investors to buy and sell units that can be created or destroyed based on demand.
Market Monitoring: Weekly monitoring of shares outstanding helps identify ETFs with significant inflows or outflows, which can affect the underlying assets held within those ETFs.
Disclaimer: The opinions expressed in the article are those of the author and do not necessarily represent the views of Nasdaq, Inc.
$3B Flows into This Russell 2000 ETF — Could a Small-Cap Rally Be Coming in 2026?
Significant Inflows into Small Cap ETF: The iShares Russell 2000 ETF (IWM) experienced a remarkable inflow of $2.78 billion during the Thanksgiving week, contributing to a total of $3.7 billion added to its assets under management in November, indicating a strategic shift among investors towards small caps.
Market Dynamics and Investor Sentiment: The inflow into IWM suggests a growing conviction that small caps may outperform as expectations for rate cuts strengthen and inflation eases, especially as larger tech-focused ETFs like Invesco QQQ Trust (QQQ) faced notable outflows.
Potential for Small Cap ETFs: Other ETFs, such as the Vanguard Small-Cap ETF (VB) and Avantis U.S. Small Cap Value ETF (AVUV), are highlighted as potential vehicles for investors looking to capitalize on the anticipated resurgence of small caps, each catering to different investment strategies.
Broader Market Implications: The sudden interest in small caps may signal a shift in investor focus from mega-cap stocks to more diversified opportunities, suggesting that market participants are preparing for a potential leadership change in the equity landscape as financial conditions stabilize.
Kratos Secures Contract Valued at One-Third of Its Fiscal 2025 Revenue – KTOS Stock Soars in Early Trading
Kraton’s New Contract: Kratos has been awarded a $446.8 million contract to serve as the prime contractor supporting the U.S. Space Force's Systems Command, focusing on ground management and integration for missile warning and tracking programs.
Revenue Growth: The contract is expected to contribute significantly to Kratos' revenue, which is projected to reach $1.35 billion in 2025, reflecting a nearly 17% growth compared to 2024.
Team Composition: Kratos will lead a team that includes Northrop Grumman, AURIA, ASRC Federal Systems Solutions, and Rise8, aiming to unify legacy and next-generation ground assets into a scalable global network.
Stock Performance: Following the contract announcement, Kratos shares rose nearly 7%, and the company has seen a year-to-date stock increase of 2% and a 167% rise over the past 12 months.
MDGL Stock Rises Significantly in a Month Amid Eli Lilly Acquisition Rumors
Madrigal's Focus: Madrigal is concentrating on developing therapies for metabolic dysfunction associated with MASH, with its Rezdiffran drug already approved by the U.S. FDA for treating moderate to advanced fibrosis.
Financial Performance: The company reported Rezdiffran sales of $958.4 million for the full year 2025, with over 36,250 patients on the drug by the end of that year.
Expansion Plans: Madrigal has licensed global rights to six pre-clinical siRNA programs for up to $4.4 billion to expand its pipeline and is evaluating the drug for treating compensated MASH cirrhosis.
Market Reaction: Following speculation about a potential buyout by Eli Lilly, Madrigal's stock saw a significant increase, with retail sentiment shifting from neutral to extremely bullish.
The Case for Retirees to Welcome Market Volatility
- Market Uncertainty: High levels of uncertainty in the market can be beneficial for stocks, contrary to the common belief that it leads to negative outcomes.
- Retirement Portfolio Consideration: Investors should keep in mind the potential positive effects of uncertainty when managing their retirement portfolios.
Vanguard Small-Cap ETF announces quarterly payout of $0.9268
Dividend Information: Vanguard Small-Cap ETF (VB) has a dividend of $0.9268, with a 30-Day SEC Yield of 1.33% as of November 30. The dividend is payable on December 24 for shareholders of record on December 22, with an ex-dividend date also on December 22.
Market Sentiment: Small-cap stocks, represented by the Vanguard Small-Cap ETF, are currently out of favor in the market, which may present compelling investment opportunities according to Seeking Alpha’s analysis.
Significant ETF Withdrawals Observed - VB, SOFI, NRG, EME
Stock Performance: VB's share price is currently at $259.74, within a 52-week range of $190.27 to $261.76, indicating a relatively stable position near its high.
ETFs Overview: Exchange traded funds (ETFs) function like stocks, allowing investors to buy and sell units that can be created or destroyed based on demand.
Market Monitoring: Weekly monitoring of shares outstanding helps identify ETFs with significant inflows or outflows, which can affect the underlying assets held within those ETFs.
Disclaimer: The opinions expressed in the article are those of the author and do not necessarily represent the views of Nasdaq, Inc.
$3B Flows into This Russell 2000 ETF — Could a Small-Cap Rally Be Coming in 2026?
Significant Inflows into Small Cap ETF: The iShares Russell 2000 ETF (IWM) experienced a remarkable inflow of $2.78 billion during the Thanksgiving week, contributing to a total of $3.7 billion added to its assets under management in November, indicating a strategic shift among investors towards small caps.
Market Dynamics and Investor Sentiment: The inflow into IWM suggests a growing conviction that small caps may outperform as expectations for rate cuts strengthen and inflation eases, especially as larger tech-focused ETFs like Invesco QQQ Trust (QQQ) faced notable outflows.
Potential for Small Cap ETFs: Other ETFs, such as the Vanguard Small-Cap ETF (VB) and Avantis U.S. Small Cap Value ETF (AVUV), are highlighted as potential vehicles for investors looking to capitalize on the anticipated resurgence of small caps, each catering to different investment strategies.
Broader Market Implications: The sudden interest in small caps may signal a shift in investor focus from mega-cap stocks to more diversified opportunities, suggesting that market participants are preparing for a potential leadership change in the equity landscape as financial conditions stabilize.
